Company news

NovaBridge Biosciences news in 2026

NovaBridge Biosciences's news releases, calls and decks from 2026, newest first.

View company

NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer

October 28, 2026

NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development

October 25, 2026

Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia

October 20, 2026

Calls in 2026

Decks in 2026